TB

TBG Diagnostics Ltd

  • CIK: 0000943502
  • EIN: 00-0000000
  • Business address: 2806 IPSWICH RD, DARRA QUEENSLAND, Australia, 4076

Information

  • Mailing address
    101 COLLINS STREET, LEVEL 18, MELBOURNE VICTORIA, Australia, 3000
  • Phone
    61732739100
  • State location
    Australia
  • State of incorporation
    Australia
  • Fiscal year end
    June 30
  • SIC
    2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
  • Filings
    N/A

About TBG Diagnostics Ltd

TBG Diagnostics Ltd (CIK: 0000943502) is an American company incorporated in the state of Australia. Head office is located at 2806 IPSWICH RD, DARRA QUEENSLAND, Australia, 4076. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. TBG Diagnostics Ltd is a public company and trade via Over-The-Counter (OTC).

Old names:

  • PROGEN PHARMACEUTICALS LTD from 2007-30-Mar to 2016-01-Feb
  • PROGEN INDUSTRIES LTD from 2002-08-Oct to 2007-29-Mar

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TBG Diagnostics Ltd

Filings Format Description Filed/Effective File/Film Number
15F-12G Document

Notice of termination of a foreign private issuer’s registration of a class of securities under Section 12(g)

Acc-no: 0001437749-16-036621 (34 Act) Size: 32 KB		 Aug-05-2016

000-29228

161812091
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-036620 (34 Act) Size: 31 KB		 Aug-05-2016

001-33617

161812083
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-035699 (34 Act) Size: 33 KB		 Jul-27-2016

001-33617

161785559
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-035572 (34 Act) Size: 38 KB		 Jul-25-2016

001-33617

161780790
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-035336 (34 Act) Size: 43 KB		 Jul-19-2016

001-33617

161772409
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-035250 (34 Act) Size: 689 KB		 Jul-15-2016

001-33617

161768451
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-032987 (34 Act) Size: 47 KB		 May-31-2016

001-33617

161683771
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-032795 (34 Act) Size: 44 KB		 May-26-2016

001-33617

161676181
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-032165 (34 Act) Size: 31 KB		 May-18-2016

001-33617

161659372
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-031893 (34 Act) Size: 6695 KB		 May-16-2016

001-33617

161650433
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-031720 (34 Act) Size: 184 KB		 May-13-2016

001-33617

161645378
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-030846 (34 Act) Size: 103 KB		 May-05-2016

001-33617

161621452
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-027638 (34 Act) Size: 36 KB		 Mar-15-2016

001-33617

161505499
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-026755 (34 Act) Size: 46 KB		 Mar-03-2016

001-33617

161482493
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-026092 (34 Act) Size: 7061 KB		 Feb-26-2016

001-33617

161457857
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-024690 (34 Act) Size: 60 KB		 Feb-04-2016

001-33617

161386721
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-024579 (34 Act) Size: 653 KB		 Feb-03-2016

001-33617

161383092
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-024577 (34 Act) Size: 630 KB		 Feb-03-2016

001-33617

161383090
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-024360 (34 Act) Size: 33 KB		 Feb-01-2016

001-33617

161375359
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001437749-16-024357 (34 Act) Size: 43 KB		 Feb-01-2016

001-33617

161375357

Recent 20 filings. View all TBG Diagnostics Ltd filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Frequently Asked Questions

Tags:

  • TBG Diagnostics Ltd overview
  • TBG Diagnostics Ltd job
  • TBG Diagnostics Ltd stock
  • TBG Diagnostics Ltd ownership
  • TBG Diagnostics Ltd CEO
  • TBG Diagnostics Ltd documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Cordyceps Sunshine Biotech Holdings Co., Ltd.
Update: Jan 21, 2023
PSLY.COM, Inc.
Update: Aug 29, 2022
Jushi Holdings Inc.
Update: Aug 29, 2022
ZACHARY VENTURES INC
Update: Aug 25, 2022
WEIKANG BIO-TECHNOLOGY GROUP CO., INC.
Update: Aug 25, 2022
VITAQUEST INTERNATIONAL INC
Update: Aug 24, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2731 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4372 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 1707 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1291 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 3699 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2666 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3108 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3411 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 1099 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by